Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Artelo Biosciences, Inc. - Common Stock (NQ:ARTL)

10.54 +7.35 (+230.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Artelo Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Why Is Micro-Cap Artelo Biosciences Stock Trading Higher On Monday? ↗
Artelo reports favorable Phase 1 results for its FABP5 inhibitor, showing strong safety data and dose-dependent absorption in 49 healthy participants. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
This UnitedHealth Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗
 
Via Benzinga
News headline image
EXCLUSIVE: Artelo Biosciences' New Peer-Reviewed Research Shows Effectiveness Of Psoriasis Candidate In Animal Models ↗
Artelo Biosciences advances ART26.12 for psoriasis and CIPN, while ART27.13 shows early promise in cancer-related anorexia studies. 
Via Benzinga
News headline image
Recap: Artelo Biosciences Q4 Earnings ↗
 
Via Benzinga
News headline image
Recap: Artelo Biosciences Q3 Earnings ↗
 
Via Benzinga
News headline image
Artelo Q2 Net Loss Declines 33% YoY, Here Is What You Need To Know ↗
Artelo Biosciences, Inc. 
Via Benzinga
News headline image
Artelo Biosciences: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
EXCLUSIVE: Artelo Biosciences Concludes First Cohort Of Healthy Volunteers Of FABP Inhibitor Program ↗
Artelo Biosciences advances its pipeline with ART26.12 for neuropathic pain and ART27.13 for cancer-related anorexia, targeting 2025 milestones. 
Via Benzinga
News headline image
ARTL Stock Earnings: Artelo Biosciences Beats EPS for Q2 2024 ↗
ARTL stock results show that Artelo Biosciences beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
ARTL Stock Earnings: Artelo Biosciences Beats EPS for Q1 2024 ↗
ARTL stock results show that Artelo Biosciences beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
ARTL Stock Earnings: Artelo Biosciences Misses EPS for Q4 2023 ↗
ARTL stock results show that Artelo Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for... 
Via Benzinga
News headline image
Why WestRock Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
We're diving into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Cannabis Stock Gainers And Losers From August 24, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Five Studies Point To Effectiveness Of Artelo Biosciences' CBD Drug Candidate For Cancer Pain – FDA IND Application The Next Step ↗
Greg Gorgas, President & CEO of Artelo Biosciences (NASDAQ: ARTL), was recently a guest on Benzinga’s All-Access. 
Via Benzinga
News headline image
Marijuana Stock Movers For August 15, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Artelo Unvails New Data On ART26.12 Demonstrating Positive Effects In Multiple Models Of Neuropathic Pain ↗
Professor Saoirse O’Sullivan, vice president of translational sciences at Artelo Biosciences, Inc. 
Via Benzinga
News headline image
Cannabis Stock Movers For July 24, 2023 ↗
 
Via Benzinga
News headline image
Artelo Biosciences Presents Groundbreaking Research At Annual CBD Symposium In Canada ↗
Artelo Biosciences, Inc. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.